It’s only fair to share… Bretisilocin CAS2698331-35-8 MF C13H17FN2 MW220.29 g/mol N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amineserotonin (5-HT2A) receptor agonist, GM-2505, GM 2505, 5-Fluoro-N-methyl-N-ethyltryptamine, 5F-MET, 5-F-MET, 5-Fluoro-MET, DS425RQ8SX Bretisilocin, also known by its developmental code name GM-2505 and as 5-fluoro-N-methyl-N-ethyltryptamine (5F-MET or 5-fluoro-MET), is a serotonergic psychedelic of the tryptamine family which is under development for the treatment of major depressive disorder.[1][7][2][3] It is an analogue of dimethyltryptamine (DMT) and is the 5-fluorinated derivative of methylethyltryptamine (MET).[8] Bretisilocin’s route of administration is intravenous infusion.[1][2][3][4] The …